GlobalRPh RX List - XYWAV
- Product / population
- XYWAV oral mixed-salt oxybates; not sodium-only XYREM.
- Renal measure
- Renal pharmacokinetics not studied.
RX mirror: this is not independent corroboration of its underlying label. Check dated-label and formulation limitations.
Renal dosing, restrictions and evidence limits
No pharmacokinetic study in renal impairment has been conducted. This mixed-salt formulation is not established as a renal-safe substitute by that absence of data. Its product-specific indication, regimen and electrolyte composition require review; do not assign the XYREM sodium-content table to XYWAV or assume identical renal evidence.